Discover
BIAF
bioAffinity Technologies, Inc.
0.48
1 x 0.48
4 x 0.49
bid
ask
-
0.01
1.29%
12:36 PM
timesize
| Ytd | -59.01% | |
| 1y | -94.22% |
0.46
day range
0.50
0.46
52 week range
13.50
| Open | 0.49 | Prev Close | 0.49 | Low | 0.46 | High | 0.50 | Mkt Cap | 3.04M |
| Vol | 152.83K | Avg Vol | 390.22K | EPS | -8.52 | P/E | -0.06 | Forward P/E | -1.58 |
| Beta | -1.05 | Short Ratio | 1.43 | Inst. Own | 3.03% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-14 | 50-d Avg | 0.94 | 200-d Avg | 1.65 | 1yr Est | 6.00 |
| Income Statement | |||
| Total Revenue | 1.51M | ||
| Revenues (USD) | 1.51M | ||
| Cost of Revenue | 1.09M | ||
| Gross Profit | 422.74K | ||
| Operating Expenses | 3.76M | ||
| Research and Development Expense | 361.58K | ||
| Selling, General and Administrative Expense | 2.86M | ||
| Operating Income | -3.33M | ||
| Interest Expense | 11.69K | ||
| Net Income | -3.37M | ||
| Net Income Common Stock | -3.37M | ||
| Net Income Common Stock (USD) | -3.37M | ||
| Consolidated Income | -3.37M | ||
| Earnings per Basic Share | -0.64 | ||
| Earnings per Basic Share (USD) | -0.64 | ||
| Earnings per Diluted Share | -0.64 | ||
| Earning Before Interest & Taxes (EBIT) | -3.35M | ||
| Earning Before Interest & Taxes (USD) | -3.35M | ||
| Weighted Average Shares | 5.23M | ||
| Weighted Average Shares Diluted | 5.23M | ||
| Balance Sheet | |||
| Cash and Equivalents | 2.43M | ||
| Cash and Equivalents (USD) | 2.43M | ||
| Trade and Non-Trade Receivables | 894.82K | ||
| Current Assets | 3.87M | ||
| Property, Plant & Equipment Net | 1.65M | ||
| Total Assets | 7.62M | ||
| Debt Current | 265.43K | ||
| Total Debt | 1.44M | ||
| Current Liabilities | 2.68M | ||
| Debt Non-Current | 1.17M | ||
| Total Liabilities | 3.85M | ||
| Accumulated Retained Earnings (Deficit) | -75.55M | ||
| Shareholders Equity | 3.77M | ||
| Shareholders Equity (USD) | 3.77M | ||
| Assets Non-Current | 3.75M | ||
| Total Debt (USD) | 1.44M | ||
| Deferred Revenue | 31.14K | ||
| Goodwill and Intangible Assets | 2.09M | ||
| Inventory | 82.38K | ||
| Liabilities Non-Current | 1.17M | ||
| Trade and Non-Trade Payables | 969.85K | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 61.56K | ||
| Net Cash Flow from Financing | 2.62M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -668.65K | ||
| Capital Expenditure | -89.97K | ||
| Issuance (Purchase) of Equity Shares | 2.69M | ||
| Issuance (Repayment) of Debt Securities | -66.12K | ||
| Net Cash Flow from Investing | -89.97K | ||
| Net Cash Flow from Operations | -3.20M | ||
| Share Based Compensation | 784.94K | ||